210 related articles for article (PubMed ID: 28436252)
21. [A Case of Gastric Cancer with Peritoneal Dissemination Effectively Treated with Ramucirumab and Paclitaxel].
Seo S; Suzuki T; Misumi T; Tashiro H
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1305-1307. PubMed ID: 29394615
[TBL] [Abstract][Full Text] [Related]
22. Third-line chemotherapy with paclitaxel, irinotecan hydrochloride and cisplatin for recurrent gastric cancer: a case report.
Takahashi N; Suzuki H; Iwabuchi S; Yamazaki Y; Yanaga K
Hepatogastroenterology; 2005; 52(61):326-8. PubMed ID: 15783061
[TBL] [Abstract][Full Text] [Related]
23. [A Case of Advanced Gastric Cancer Treated Effectively with Combination Chemotherapy of Paclitaxel plus Ramucirumab].
Masano Y; Moriyama H; Murata T; Sato B; Usui Y
Gan To Kagaku Ryoho; 2019 Aug; 46(8):1299-1302. PubMed ID: 31501374
[TBL] [Abstract][Full Text] [Related]
24. Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China.
Li S; Peng L; Tan C; Zeng X; Wan X; Luo X; Yi L; Li J
PLoS One; 2020; 15(5):e0232240. PubMed ID: 32379763
[TBL] [Abstract][Full Text] [Related]
25. [A Case of an Elderly Patient with Unresectable Gastric Cancer Treated by Paclitaxel and Ramucirumab].
Kimura Y; Makari Y; Mikami J; Yoshimura J; Inoue T; Sawada G; Nakahira S; Yamamura J; Kamigaki S; Nakata K; Yamamoto T; Ikeda N; Tsujie M; Fujita J; Ohzato H
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2404-2406. PubMed ID: 28133336
[TBL] [Abstract][Full Text] [Related]
26. A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer.
Bando H; Shimodaira H; Fujitani K; Takashima A; Yamaguchi K; Nakayama N; Takahashi T; Oki E; Azuma M; Nishina T; Hironaka S; Komatsu Y; Shitara K
Eur J Cancer; 2018 Mar; 91():86-91. PubMed ID: 29353164
[TBL] [Abstract][Full Text] [Related]
27. [Three Patients with Gastric Cancer Who Underwent Surgery during Ramucirumab Treatment].
Omori H; Kawai S; Makuuchi R; Irino T; Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Yasui H; Terashima M
Gan To Kagaku Ryoho; 2017 Nov; 44(11):1021-1023. PubMed ID: 29138380
[TBL] [Abstract][Full Text] [Related]
28. Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial.
Nishikawa K; Fujitani K; Inagaki H; Akamaru Y; Tokunaga S; Takagi M; Tamura S; Sugimoto N; Shigematsu T; Yoshikawa T; Ishiguro T; Nakamura M; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J; Tsujinaka T
Eur J Cancer; 2015 May; 51(7):808-16. PubMed ID: 25797356
[TBL] [Abstract][Full Text] [Related]
29. Safety and continuity of second- and third-line therapy with paclitaxel or irinotecan for advanced and recurrent gastric cancer.
Kimura M; Usami E; Kanematsu T; Iwai M; Yoshimura T; Mori H; Sugiyama T; Teramachi H
Mol Clin Oncol; 2014 May; 2(3):466-472. PubMed ID: 24772319
[TBL] [Abstract][Full Text] [Related]
30. A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.
Matsumoto H; Kawazoe A; Shimada K; Fukuoka S; Kuboki Y; Bando H; Kojima T; Ohtsu A; Yoshino T; Doi T; Shitara K
BMC Cancer; 2018 Jan; 18(1):120. PubMed ID: 29385993
[TBL] [Abstract][Full Text] [Related]
31. Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer.
Kurimoto M; Kimura M; Usami E; Iwai M; Hirose T; Kawachi S; Yoshimura T
Mol Clin Oncol; 2017 Jul; 7(1):125-130. PubMed ID: 28685089
[TBL] [Abstract][Full Text] [Related]
32. Phase I/II study of irinotecan (CPT-11) and S-1 in the treatment of advanced gastric cancer.
Katsube T; Ogawa K; Ichikawa W; Fujii M; Tokunaga A; Takagi Y; Kochi M; Hayashi K; Kubota T; Aiba K; Arai K; Terashima M; Kitajima M
Anticancer Drugs; 2007 Jun; 18(5):605-10. PubMed ID: 17414630
[TBL] [Abstract][Full Text] [Related]
33. [A Case of Advanced Gastric Cancer with Peritoneal Dissemination after Gastrectomy Successfully Treated with Paclitaxel plus Ramucirumab].
Miyamoto K; Tadano Y; Itoh R
Gan To Kagaku Ryoho; 2021 Jan; 48(1):113-114. PubMed ID: 33468738
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of Neutropenia and Usages of Antihypertensive Drugs in Patients Treated with Ramucirumab plus Paclitaxel Therapy].
Kawaguchi M; Kawakami K; Aoyama T; Tomomatsu T; Hama T; Takahari D; Chin K; Yamaguchi K; Yamaguchi M
Gan To Kagaku Ryoho; 2022 Aug; 49(8):873-878. PubMed ID: 36046973
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naïve patients with HER2-positive, previously treated, advanced, or recurrent gastric cancer (JFMC45-1102).
Nishikawa K; Takahashi T; Takaishi H; Miki A; Noshiro H; Yoshikawa T; Nishida Y; Iwasa S; Miwa H; Masuishi T; Boku N; Yamada Y; Kodera Y; Yoshida K; Morita S; Sakamoto J; Saji S; Kitagawa Y
Int J Cancer; 2017 Jan; 140(1):188-196. PubMed ID: 27521503
[TBL] [Abstract][Full Text] [Related]
36. Retrospective evaluation of sequential outpatient chemotherapy for advanced gastric cancer.
Satoh S; Kawashima K; Matsumoto S; Hasegawa S; Okabe H; Nomura A; Yoshibayashi H; Watanabe G; Nagayama S; Fukushima M; Sakai Y
Chemotherapy; 2007; 53(3):226-32. PubMed ID: 17356271
[TBL] [Abstract][Full Text] [Related]
37. [A Thoracic Aortic Dissection Case during Treatment with Ramucirumab plus Nab-Paclitaxel].
Nikai H; Akiyama Y; Fujisawa R; Endo F; Baba S; Koeda K; Sasaki A
Gan To Kagaku Ryoho; 2020 Jun; 47(6):981-983. PubMed ID: 32541179
[TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine Carcinoma of the Stomach: A Response to Combination Chemotherapy Consisting of Ramucirumab Plus Paclitaxel.
Matsubara Y; Ando T; Hosokawa A; Mihara H; Takagi H; Nakata N; Yoshita H; Nanjo S; Kajiura S; Fujinami H; Sugiyama T
Intern Med; 2018 Mar; 57(5):671-675. PubMed ID: 29151523
[TBL] [Abstract][Full Text] [Related]
39. Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer.
Otsuka R; Iwasa S; Yanai T; Hirano H; Shoji H; Honma Y; Okita N; Takashima A; Kato K; Hashimoto H; Sekiguchi M; Makino Y; Boku N; Yamaguchi M
Int J Clin Oncol; 2020 Apr; 25(4):595-601. PubMed ID: 31853798
[TBL] [Abstract][Full Text] [Related]
40. Comparative cost-effectiveness of bevacizumab-irinotecan-fluorouracil versus irinotecan-fluorouracil in first-line metastatic colorectal cancer.
Ruiz-Millo O; Albert-Mari A; Sendra-Garcia A; Jimenez-Torres NV
J Oncol Pharm Pract; 2014 Oct; 20(5):341-50. PubMed ID: 24177355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
